DeveloGen AG receives US$ 500,000 Funding from the Juvenile Diabetes Research Foundation for Beta Cell Research

Göttingen, 23 February 2010. DeveloGen AG, a company focused on the discovery and development of therapies for the treatment of diabetes and other metabolic diseases announced today that it will receive US$ 500,000 from the Juvenile Diabetes Research Foundation, New York, USA (JDRF). The funds are dedicated to aide in the research of mechanisms for the protection of beta cells. In this two year project titled "Development of Novel Therapeutic Agents Enhancing Human Beta Cell Survival",...

Obesity And Diabetes Study Weighs Influence Of Genetics, Lifestyle

A team of Northern Arizona University-led researchers is using nearly $1.3 million in new funding from the National Institutes of Health to continue with the world's longest-running study on obesity and Type 2...

Diabetes patients rank health concerns differently than their doctors, survey shows

About one-third of doctors and their patients with diabetes do not see eye to eye on the most important health conditions to manage, according to a survey by the University of Michigan Medical...

Envoy Enters Diabetes and Obesity Collaboration with Merck & Co., Inc.

Envoy Therapeutics, Inc. today announced that it has entered into a multi-year research collaboration agreement with an affiliate of Merck & Co., Inc. to discover novel diabetes and obesity drug targets. Under the agreement, Envoy will use its proprietary bacTRAP® technology to identify proteins expressed specifically in certain cell types. Merck will then work to identify and develop compounds that modulate protein targets with therapeutic potential for the treatment of metabolic...

JDRF and BD Collaborate to Improve Insulin Pump Delivery

R&D Program Targets Opportunities to Improve Glucose Control and Help People with Diabetes Lead Healthier Lives NEW YORK and FRANKLIN LAKES, N.J., Jan. 19 /PRNewswire-USNewswire/ -- The Juvenile Diabetes Research Foundation (JDRF) and BD (Becton, Dickinson and Company) (NYSE: BDX) announced...

Cancer, Heart Disease, Stroke, Diabetes, Chronic Pain and Depression Share a Major Pathology Factor

For humans, sunlight and vitamin D is critically important for the development, growth, and maintenance of a healthy body, from birth until death. "Humans make thousands of units of vitamin D within minutes of whole body exposure to sunlight. From what we know of nature, it is unlikely such a system evolved by chance," states Dr. John Cannell, Executive Director, Vitamin D Council. According to the Vitamin D Council, current research has implicated sunlight and vitamin D deficiency as a major...

New Recommendation on Diabetes Lab Test Will Aid in Battling the Disease, Says Lab Group

Convenience of non-fasting diabetes test could encourage testing WASHINGTON, Jan. 8 /PRNewswire-USNewswire/ -- The American Clinical Laboratory Association's Results for Life Campaign today applauded the American Diabetes Association for its decision to recommend the hemoglobin A1C laboratory test as a means of diagnosing diabetes and identifying pre-diabetes. The new ADA clinical practice recommendation was published as a supplement to the January issue of Diabetes Care. "This...

Tolerx Completes Enrollment In DEFEND-1, A Phase 3 Type 1 Diabetes Study With Otelixizumab

Tolerx, Inc., announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety and efficacy of otelixizumab, a targeted T cell immunomodulator, in patients with new-onset autoimmune type 1...

New Discovery By Harvard Scientists Aims To Correct Cellular Defects Leading To Diabetes

A new research discovery published online in the FASEB Journal may change the perception and treatment of diabetes. That's because scientists have moved closer toward correcting the root cause of the disease rather than managing its...

Study shows diabetic patients can benefit from gastric bypass surgery

Bariatric surgery is a procedure designed to help patients lose weight, but an unexpected side effect is that it can also help rid patients of...